Search
Advertisement
Valcreate - Lifesciences and Specialty Opportunities
Valcreate - Lifesciences and Specialty Opportunities

Valcreate - Lifesciences and Specialty Opportunities

  • Valcreate Investment Managers LLP
  • Thematic
  • 5
    Out of 12*
  • Compare
    Compare
  • Share
    • Whatsapp
    • Twitter
    • Facebook
    Share
Powered by
PMS Bazaar
Portfolio age3 years, 1 month
8.77%
0.45%
Hurdle Rate**10.00%
Fixed fee2.50%
Min. Investment50 Lacs
*Ranking of the scheme in the peer group is based on its return for the longest period available
**Minimum return that a PMS scheme must generate before an investor starts paying performance fees

bt_logoTRAILING PERFORMANCE

(As on 28/02/2026)
Compare the performance of the PMS scheme against benchmark across different time periods.

bt_logoPERFORMANCE

Calendar YearFinancial Year
No Data Available

bt_logoDETAILED PORTFOLIO

EQUITY (Undisclosed)
Allocation by Market Cap
Undisclosed
Sector Holdings
Undisclosed
Stock Holdings
Undisclosed

bt_logoPORTFOLIO MANAGERS

Rajesh Pherwani
  • Manager Rank5 Out of 12
    i
    Rank is based on 3-year return
  • Schemes Managed2
  • Total AUMUndisclosed
  • Highest Return In 1 Yr26.81%
Profile

Rajesh has over 25 years of investing experience, including HDFC Ltd, HDFC AMC and L&T AMC. Rajesh is a BE, MBA & CFA.

Other Schemes
AUM (₹ Cr)
UNDISC.
Hurdle Rate
10.00%
Benchmark
S&P BSE 500 TRI
Category
Thematic
Category Rank
1 Out of 21
Fixed Fee
2.50%
AUM (₹ Cr)
UNDISC.
Hurdle Rate
10%
Benchmark
S&P BSE 500 TRI
Category
Multi Cap AND Flexi Cap
Category Rank
24 Out of 263
Fixed Fee
2.50%
*Returns less than and equal to 1 year are absolute and returns above one year are annualized

BT Tv

bt_logoPEER ANALYSIS

AUM (₹ Cr)
UNDISC.
Hurdle Rate
10.00%
Benchmark
S&P BSE 500 TRI
Category Rank
1 Out of 21
Fixed Fee
2.50%
AUM (₹ Cr)
₹33.52 Cr
Hurdle Rate
12%
Benchmark
Nifty 50 TRI
Category Rank
2 Out of 21
Fixed Fee
1.75%
AUM (₹ Cr)
₹24.53 Cr
Hurdle Rate
10%
Benchmark
S&P BSE 500 TRI
Category Rank
3 Out of 21
Fixed Fee
2.25%
AUM (₹ Cr)
₹141.40 Cr
Hurdle Rate
No Option
Benchmark
S&P BSE 500 TRI
Category Rank
4 Out of 21
Fixed Fee
2.50%
AUM (₹ Cr)
UNDISC.
Hurdle Rate
Benchmark
Benchmark
S&P BSE 500 TRI
Category Rank
5 Out of 21
Fixed Fee
2.50%
AUM (₹ Cr)
₹436.30 Cr
Hurdle Rate
10%
Benchmark
S&P BSE 500 TRI
Category Rank
6 Out of 21
Fixed Fee
2.00%
*Returns less than and equal to 1 year are absolute and returns above one year are annualized

bt_logoABOUT AMC

Valcreate Investment Managers LLP
Valcreate Investment Managers LLP manages assets worth Rs 54.86 crores. Its current offering of PMS schemes includes 1 Thematic and 1 Multi Cap And Flexi Cap schemes.

AUM (₹ cr)

54.86 (As on Feb, 2026)

Number of Schemes

2
Schemes From This AMC
AUM (₹ Cr)
UNDISC.
Hurdle Rate
10.00%
Benchmark
S&P BSE 500 TRI
Category
Thematic
Category Rank
1 Out of 21
Fixed Fee
2.50%
AUM (₹ Cr)
UNDISC.
Hurdle Rate
10%
Benchmark
S&P BSE 500 TRI
Category
Multi Cap AND Flexi Cap
Category Rank
24 Out of 263
Fixed Fee
2.50%
*Returns less than and equal to 1 year are absolute and returns above one year are annualized

bt_logoFAQ's

What is the hurdle rate of Valcreate - Lifesciences and Specialty Opportunities?
The hurdle rate of Valcreate - Lifesciences and Specialty Opportunities is 10.00%.
What is the fixed fee charged in Valcreate - Lifesciences and Specialty Opportunities ?
The fixed fee charged in Valcreate - Lifesciences and Specialty Opportunities is 2.50%.
What is the variable fee charged in Valcreate - Lifesciences and Specialty Opportunities ?
The variable fee charged in Valcreate - Lifesciences and Specialty Opportunities is 1.50%.
What is the profit sharing in Valcreate - Lifesciences and Specialty Opportunities ?
The profit sharing in Valcreate - Lifesciences and Specialty Opportunities is 20% Profit sharing above 10% hurdle.
What is the minimum investment in Valcreate - Lifesciences and Specialty Opportunities ?
The minimum investment in Valcreate - Lifesciences and Specialty Opportunities is ₹50 Lacs
What type of scheme is Valcreate - Lifesciences and Specialty Opportunities?
Valcreate - Lifesciences and Specialty Opportunities is an Equity scheme. It falls in the Thematic category.
What is the inception date of Valcreate - Lifesciences and Specialty Opportunities?
The inception date of Valcreate - Lifesciences and Specialty Opportunities is Feb 10, 2023.
What is the exit load of Valcreate - Lifesciences and Specialty Opportunities?
Exit load is 0%